[1]
Chakrabarty, P. et al. 2024. Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial. Asian Journal of Medical Sciences. 15, 4 (Apr. 2024), 70–77.